title: Rare coding variants of the adenosine A3 receptor are increased in autism: on the trail of the serotonin transporter regulome.
abstract: BACKGROUND
  Rare genetic variation is an important class of autism spectrum disorder (ASD) risk factors and can implicate biological networks for investigation. Altered serotonin (5-HT) signaling has been implicated in ASD, and we and others have discovered multiple, rare, ASD-associated variants in the 5-HT transporter (SERT) gene leading to elevated 5-HT re-uptake and perturbed regulation. We hypothesized that loci encoding SERT regulators harbor variants that impact SERT function and/or regulation and therefore could contribute to ASD risk. The adenosine A3 receptor (A3AR) regulates SERT via protein kinase G (PKG) and other signaling pathways leading to enhanced SERT surface expression and catalytic activity.
  
  
  METHODS
  To test our hypothesis, we asked whether rare variants in the A3AR gene (ADORA3) were increased in ASD cases vs. controls. Discovery sequencing in a case-control sample and subsequent analysis of comparison exome sequence data were conducted. We evaluated the functional impact of two variants from the discovery sample on A3AR signaling and SERT activity.
  
  
  RESULTS
  Sequencing discovery showed an increase of rare coding variants in cases vs. controls (P=0.013). While comparison exome sequence data did not show a significant enrichment (P=0.071), combined analysis strengthened evidence for association (P=0.0025). Two variants discovered in ASD cases (Leu90Val and Val171Ile) lie in or near the ligand-binding pocket, and Leu90Val was enriched individually in cases (P=0.040). In vitro analysis of cells expressing Val90-A3AR revealed elevated basal cGMP levels compared with the wildtype receptor. Additionally, a specific A3AR agonist increased cGMP levels across the full time course studied in Val90-A3AR cells, compared to wildtype receptor. In Val90-A3AR/SERT co-transfections, agonist stimulation elevated SERT activity over the wildtype receptor with delayed 5-HT uptake activity recovery. In contrast, Ile171-A3AR was unable to support agonist stimulation of SERT. Although both Val90 and Ile171 were present in greater numbers in these ASD cases, segregation analysis in families showed incomplete penetrance, consistent with other rare ASD risk alleles.
  
  
  CONCLUSIONS
  Our results validate the hypothesis that the SERT regulatory network harbors rare, functional variants that impact SERT activity and regulation in ASD, and encourages further investigation of this network for other variation that may impact ASD risk.
authors: Department of Molecular Physiology & Biophysics and Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, TN 37232-8548, USA. james.s.sutcliffe@vanderbilt.edu.
authors: Nicholas G
authors: NG
authors: Campbell
authors: Chong-Bin
authors: CB
authors: Zhu
authors: Kathryn M
authors: KM
authors: Lindler
authors: Brian L
authors: BL
authors: Yaspan
authors: Emily
authors: E
authors: Kistner-Griffin
authors: William A
authors: WA
authors: Hewlett
authors: Christopher G
authors: CG
authors: Tate
authors: Randy D
authors: RD
authors: Blakely
authors: James S
authors: JS
authors: Sutcliffe
references: Eur J Hum Genet. 2001 Apr;9(4):301-6
references: 11313775
references: Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5469-74
references: 22431635
references: Mol Psychiatry. 2006 Mar;11(3):224-6
references: 16402131
references: J Am Acad Child Adolesc Psychiatry. 2003 Jul;42(7):864-72
references: 12819447
references: Mol Psychiatry. 2003 Nov;8(11):933-6
references: 14593431
references: J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1094-1103
references: 16926617
references: Mol Pharmacol. 2011 Sep;80(3):458-65
references: 21705486
references: Neuroscience. 2011 Dec 1;197:1-7
references: 22001683
references: Nature. 2009 May 28;459(7246):528-33
references: 19404256
references: Nat Genet. 2007 Mar;39(3):319-28
references: 17322880
references: Neuropsychopharmacology. 2012 Jan;37(1):196-212
references: 21937981
references: Nature. 2012 Apr 04;485(7397):246-50
references: 22495309
references: Traffic. 2008 Sep;9(9):1393-402
references: 18445122
references: Am J Hum Genet. 2008 Sep;83(3):311-21
references: 18691683
references: J Biol Chem. 1994 Nov 4;269(44):27351-6
references: 7525554
references: Nature. 2012 Apr 04;485(7397):242-5
references: 22495311
references: Am J Hum Genet. 2006 May;78(5):815-826
references: 16642437
references: Mol Psychiatry. 2006 Dec;11(12):1073-84
references: 16940977
references: J Clin Invest. 2008 Apr;118(4):1544-52
references: 18317590
references: Philos Trans R Soc Lond B Biol Sci. 2013 Feb 25;368(1615):20120435
references: 23440468
references: PLoS Genet. 2009 Jun;5(6):e1000536
references: 19557195
references: Science. 1996 Nov 29;274(5292):1527-31
references: 8929413
references: Nat Neurosci. 2012 Feb 26;15(4):519-27
references: 22366757
references: Autism Res. 2008 Aug;1(4):251-7
references: 19360675
references: Nucleic Acids Res. 2003 Jul 1;31(13):3812-4
references: 12824425
references: Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):477-483
references: 19588468
references: Nature. 2010 Oct 28;467(7319):1061-73
references: 20981092
references: J Autism Dev Disord. 2000 Jun;30(3):205-23
references: 11055457
references: Am J Hum Genet. 2005 Jun;76(6):1050-6
references: 15877280
references: Res Dev Disabil. 2006 May-Jun;27(3):254-89
references: 16002261
references: Nature. 2008 Oct 16;455(7215):919-23
references: 18923514
references: Am J Hum Genet. 1999 Aug;65(2):493-507
references: 10417292
references: Nat Rev Neurosci. 2003 Dec;4(12):1002-12
references: 14618156
references: J Neurodev Disord. 2009 Jun;1(2):158-71
references: 19960097
references: Mol Pharmacol. 2004 Jun;65(6):1462-74
references: 15155839
references: Mutat Res. 2007 Feb 3;615(1-2):28-56
references: 17101154
references: Proc Natl Acad Sci U S A. 2005 Aug 9;102(32):11545-50
references: 16055563
references: Ups J Med Sci. 2010 Feb;115(1):2-10
references: 20187845
references: Mol Psychiatry. 2005 Dec;10(12):1110-6
references: 16103890
references: J Pharmacol Exp Ther. 2007 Jul;322(1):332-40
references: 17460150
references: Nucleic Acids Res. 2007;35(11):3823-35
references: 17526529
references: Nature. 2010 Jul 15;466(7304):368-72
references: 20531469
references: Biol Psychiatry. 2008 Jun 15;63(12):1111-7
references: 18374305
references: Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):163-73
references: 18957375
references: Bioinformatics. 2005 Jan 15;21(2):263-5
references: 15297300
references: Am J Med Genet. 1999 Dec 15;88(6):609-15
references: 10581478
references: Nat Methods. 2010 Apr;7(4):248-9
references: 20354512
references: J Pediatr. 1961 Mar;58:315-20
references: 13747230
references: Hum Mol Genet. 2010 Oct 15;19(20):4072-82
references: 20663923
references: Am J Hum Genet. 1998 Jul;63(1):259-66
references: 9634505
references: J Autism Dev Disord. 1994 Oct;24(5):659-85
references: 7814313
references: Bioinformatics. 2003 Jan;19(1):149-50
references: 12499305
references: Am J Hum Genet. 2007 Sep;81(3):559-75
references: 17701901
references: Arch Gen Psychiatry. 2011 May;68(5):457-8
references: 21536974
references: Nat Rev Neurosci. 2008 Feb;9(2):85-96
references: 18209729
references: Nature. 2011 May 18;474(7352):521-5
references: 21593763
references: Mol Psychiatry. 2011 Jan;16(1):108-20
references: 19806148
references: Neuron. 2012 Apr 26;74(2):285-99
references: 22542183
references: Genetics. 2000 Jun;155(2):945-59
references: 10835412
references: Eur J Hum Genet. 2006 Aug;14(8):923-31
references: 16724005
references: Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):903-13
references: 18286633
references: Hum Mol Genet. 2008 Feb 15;17(4):628-38
references: 18156158
references: Am J Hum Genet. 2004 Dec;75(6):1117-23
references: 15467983
references: Life Sci. 1993;52(25):2005-15
references: 7684805
references: Neuropharmacology. 2008 Nov;55(6):932-60
references: 18824000
references: Nature. 2012 Apr 04;485(7397):237-41
references: 22495306
references: Eur J Hum Genet. 2004 Nov;12(11):949-54
references: 15292919
references: Am J Hum Genet. 2005 Aug;77(2):265-79
references: 15995945
references: Hum Genet. 2006 Aug;120(1):93-100
references: 16721604
references: Science. 2007 Apr 20;316(5823):445-9
references: 17363630
references: Neuron. 2013 Jan 23;77(2):235-42
references: 23352160
references: Mol Psychiatry. 2005 Dec;10(12):1059-61
references: 16088327